Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.015
+0.435 (12.15%)
At close: Nov 17, 2026, 4:00 PM EST
4.020
+0.005 (0.12%)
Pre-market: Nov 18, 2026, 5:14 AM EST
Rezolute Employees
Rezolute had 63 employees as of September 30, 2026. The number of employees increased by 5 or 8.62% since the number was last reported on June 30, 2026. That makes Rezolute the 33,987th largest employer in the world and 4,484th in the United States.
Employees
63
Change
5
Growth
8.62%
Revenue / Employee
n/a
Profits / Employee
-$1,236,873
Market Cap
421.19M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 63 | 5 | 8.62% |
| Jun 30, 2026 | 58 | -13 | -18.31% |
| Jun 30, 2025 | 71 | 12 | 20.34% |
| Jun 30, 2024 | 59 | 8 | 15.69% |
| Jun 30, 2023 | 51 | 9 | 21.43% |
| Jun 30, 2022 | 42 | 16 | 61.54% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| Arvinas | 246 |
| CytomX Therapeutics | 69 |
| Prothena Corporation | 67 |
| Tectonic Therapeutic | 60 |
| Candel Therapeutics | 55 |
| Eupraxia Pharmaceuticals | 49 |
| DiaMedica Therapeutics | 35 |
RZLT News
- 21 hours ago - Rezolute price target raised to $10 from $6 at Wedbush - TheFly
- 1 day ago - Rezolute price target raised to $15 from $12 at Lake Street - TheFly
- 4 days ago - Rezolute Slides: Corporate presentation - Filings
- 4 days ago - Rezolute prices 22.04M shares of common stock at $3.87 - TheFly
- 4 days ago - Rezolute reports results from open-label Phase 3 upLIFT study - TheFly
- 4 days ago - Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 4 days ago - Rezolute Announces Positive Results from the Phase 3 upLIFT Study in Tumor Hyperinsulinism - GlobeNewsWire
- 8 days ago - Rezolute Transcript: Guggenheim 3rd Annual Healthcare Innovation Conference - Transcripts